226 related articles for article (PubMed ID: 36126099)
21. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.
Peng Y; Huang X; Wang H
BMC Mol Cell Biol; 2022 Jul; 23(1):34. PubMed ID: 35896973
[TBL] [Abstract][Full Text] [Related]
22. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
[TBL] [Abstract][Full Text] [Related]
23. SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway.
Li F; Xian D; Huang J; Nie L; Xie T; Sun Q; Zhang X; Zhou Y
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686205
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients' survival by downregulating miR-21.
Gao J; Wang S; Zhang Z; Li J
BMC Cancer; 2021 Jun; 21(1):745. PubMed ID: 34182945
[TBL] [Abstract][Full Text] [Related]
25. lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer.
Xia L; Wang H
Breast J; 2022; 2022():7689718. PubMed ID: 35711895
[TBL] [Abstract][Full Text] [Related]
26. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis.
Liu X; Song J; Kang Y; Wang Y; Chen A
J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517
[TBL] [Abstract][Full Text] [Related]
28. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC.
Li S; Wu D; Jia H; Zhang Z
Cell Death Dis; 2020 Aug; 11(8):643. PubMed ID: 32811810
[TBL] [Abstract][Full Text] [Related]
30. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
Jiang B; Liu Q; Gai J; Guan J; Li Q
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
[TBL] [Abstract][Full Text] [Related]
31. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells.
Liu W; Huai R; Zhang Y; Rao S; Xiong L; Ding R; Mao C; Zhao W; Hao T; Huang Q; Guo Z
Genes Genomics; 2019 Aug; 41(8):951-959. PubMed ID: 31066006
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis.
Huang D; Zhang K; Zheng W; Zhang R; Chen J; Du N; Xia Y; Long Y; Gu Y; Xu J; Deng M
J Exp Clin Cancer Res; 2021 Oct; 40(1):342. PubMed ID: 34706749
[TBL] [Abstract][Full Text] [Related]
34. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells.
Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438
[TBL] [Abstract][Full Text] [Related]
35. Differential optineurin expression controls TGFβ signaling and is a key determinant for metastasis of triple negative breast cancer.
Liu S; van Dinther M; Hagenaars SC; Gu Y; Kuipers TB; Mei H; Gomez-Puerto MC; Mesker WE; Ten Dijke P
Int J Cancer; 2023 Jun; 152(12):2594-2606. PubMed ID: 36823950
[TBL] [Abstract][Full Text] [Related]
36. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
[TBL] [Abstract][Full Text] [Related]
37.
Guardia T; Zhang Y; Thompson KN; Lee SJ; Martin SS; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2215553120. PubMed ID: 36877839
[TBL] [Abstract][Full Text] [Related]
38. The TGFB2-AS1 lncRNA Regulates TGF-β Signaling by Modulating Corepressor Activity.
Papoutsoglou P; Tsubakihara Y; Caja L; Morén A; Pallis P; Ameur A; Heldin CH; Moustakas A
Cell Rep; 2019 Sep; 28(12):3182-3198.e11. PubMed ID: 31533040
[TBL] [Abstract][Full Text] [Related]
39. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
